NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
168 hedge funds and large institutions have $1.42B invested in NxStage Medical Inc. in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 62 reducing their positions, and 25 closing their positions.
26% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $1.28M
2% more capital invested
Capital invested by funds: $1.4B → $1.42B (+$28.8M)
5% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 62
6% less funds holding
Funds holding: 178 → 168 (-10)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Flossbach Von Storch
Cologne,
Germany
|
+$72.8M |
| 2 |
TAL
TIG Advisors LLC
New York
|
+$20.4M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$18M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$10.5M |
| 5 |
BlackRock
New York
|
+$9.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$41.5M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$33.6M |
| 3 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$18M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$12M |
| 5 |
GCC
Game Creek Capital
Boston,
Massachusetts
|
-$9.82M |
NXTM Hedge Fund Activity: Q1 2018 in Review
168 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2018, worth a combined $1.42B — up 2.1% from $1.4B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of NXTM and 15 opened new positions — a net loss of 10 holders — while 62 trimmed existing stakes and 59 added.
The largest buyer was Flossbach Von Storch, opening a new position worth an estimated $72.8M. The largest seller was Invesco, cutting an estimated $41.5M.
- 168 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2018, down from 178 in Q4 2017.
- Funds reported $1.42B of NxStage Medical Inc. stock for Q1 2018, up 2.1% quarter-over-quarter.
- 15 funds opened new NxStage Medical Inc. positions in Q1 2018 and 25 closed out, a net change of -10 holders.
- The largest NxStage Medical Inc. buyer in Q1 2018 was Flossbach Von Storch, an estimated $72.8M added.
- The largest NxStage Medical Inc. seller in Q1 2018 was Invesco, an estimated $41.5M sold.
Based on aggregated 13F filings for Q1 2018.